| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |